hepatitis B

VBI Vaccines recalls hepatitis B shot as it winds down operations
Fierce Pharma
Mon, 11/18/24 - 11:17 am
VBI Vaccines
PreHevbrio
hepatitis B
vaccines
bankruptcy
Barinthus lays off 25% of staff, sidelines prostate cancer program to stretch out cash
Fierce Biotech
Thu, 06/13/24 - 10:51 am
Barinthus Biotherapeutics
hepatitis B
clinical trials
prostate cancer
layoffs
FDA declines expanded use of Dynavax's hepatitis B vaccine on insufficient data
Reuters
Tue, 05/14/24 - 11:29 am
Dynavax Technologies
vaccines
hepatitis B
HEPLISAV-B
FDA approves Gilead's Vemlidy drug for children with hepatitis B
Investing.com
Thu, 03/28/24 - 05:08 pm
Gilead Sciences
FDA
Vemlidy
hepatitis B
pediatric
Altimmune bails on hepatitis B after phase 2 data disappoint, quashing partnering plans
Fierce Biotech
Wed, 03/27/24 - 10:38 pm
Altimmune
hepatitis B
clinical trials
HepTcell
Assembly Bio to launch four infectious disease trials in 2024
Clinical Trials Arena
Mon, 03/18/24 - 11:14 am
Assembly Bio
clinical trials
herpes simplex virus
hepatitis B
hepatitis D
FDA fast-tracks GSK’s chronic hep B therapy bepirovirsen
Pharmaphorum
Mon, 02/12/24 - 10:28 am
GSK
FDA
fast track
hepatitis B
bepirovirsen
antisense
Hepatitis B drug developers chart slow progress forward, just like hep C before it
Fierce Biotech
Tue, 11/14/23 - 09:35 am
hepatitis B
hepatitis C
drug development
Assembly Biosciences
GSK
Aligos Therapeutics
Vaccitech reemerges as Barinthus with hep B data showing declines in infection levels
Fierce Biotech
Fri, 11/10/23 - 12:05 pm
Barinthus Biotherapeutics
Vaccitech
clinical trials
hepatitis B
GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy
Reuters
Tue, 10/31/23 - 10:18 am
GSK
JNJ
hepatitis B
JNJ-3989
Janssen
Gilead pays $100M for first dibs on all Assembly Bio assets, bolting antiviral engine to its R&D group
Fierce Biotech
Tue, 10/17/23 - 10:27 am
Gilead Sciences
Assembly Biosciences
antivirals
hepatitis B
Aligos culls another hepatitis B asset, citing inconclusive efficacy data
Fierce Biotech
Fri, 08/4/23 - 10:12 am
Algios Therapeutics
hepatitis B
siRNA
Gilead reports positive results in HDV patients previously unresponsive to therapy
Motley Fool
Sun, 06/25/23 - 09:35 pm
Gilead Sciences
MYR301
Hepcludex
hepatitis B
clinical trials
Bluejay Therapeutics makes progress in Hepatitis B and D Trials
Clinical Trials Arena
Fri, 06/2/23 - 10:20 am
Bluejay Therapeutics
clinical trials
BJT-778
hepatitis B
hepatitis D
Vaccitech’s chronic Hepatitis B drug sees positive topline data
Clinical Trials Arena
Wed, 03/29/23 - 04:06 pm
Vaccitech
VTP-300
clinical trials
hepatitis B
GSK moves hepatitis B drug into late-stage testing
BioPharma Dive
Thu, 02/2/23 - 11:01 pm
GSK
bepirovirsen
clinical trials
hepatitis B
Emerging from hepatitis B flops, Assembly Bio showcases early data on next-gen drugs
Endpoints
Mon, 12/19/22 - 12:13 pm
Assembly Biosciences
John McHutchison
hepatitis B
ABI-H3733
GSK plans phase 3 for hepatitis B drug bepirovirsen, despite efficacy drop
Pharmaphorum
Wed, 11/9/22 - 10:49 am
GSK
hepatitis B
bepirovirsen
clinical trials
Roche Scraps Mid-Phase Programs in Hepatitis B, Geographic Atrophy
BioSpace
Tue, 10/18/22 - 10:01 pm
Roche
hepatitis B
geographic atrophy
Bluejay raises $41M to bring hepatitis B drugs to clinical testing
BioPharma Dive
Fri, 08/19/22 - 10:39 am
Bluejay Therapeutics
hepatitis B
funding

Pages